Edwards Lifesciences Corporation (EW) Free cash flow 2016–2025
Edwards Lifesciences Corporation (EW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$1.3BFY2025 · since FY2016: $528.3M → $1.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.3B | +360.5% |
| FY2024 | $289.9M | -54.9% |
| FY2023 | $642.8M | -34.0% |
| FY2022 | $973.6M | -30.8% |
| FY2021 | $1.4B | +117.3% |
| FY2020 | $647.3M | -30.3% |
| FY2019 | $928.5M | +35.0% |
| FY2018 | $688.0M | -17.4% |
| FY2017 | $832.6M | +57.6% |
| FY2016 | $528.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice